無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

マトリックス誘導性自家軟骨形成市場の動向と予測:材料(ヒアルロン酸、コラーゲン、ポリエチレングリコール、乳酸‐グリコール酸共重合体)別

Autologous Matrix-induced Chondrogenesis Market (Material - Hyaluronic Acid, Collagen, Polyethylene Glycol (PEG), and Poly Lactic-Co-Glycolic Acid (PGLA)) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

発行 Transparency Market Research 商品コード 449985
出版日 ページ情報 英文 114 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.02円で換算しております。
Back to Top
マトリックス誘導性自家軟骨形成市場の動向と予測:材料(ヒアルロン酸、コラーゲン、ポリエチレングリコール、乳酸‐グリコール酸共重合体)別 Autologous Matrix-induced Chondrogenesis Market (Material - Hyaluronic Acid, Collagen, Polyethylene Glycol (PEG), and Poly Lactic-Co-Glycolic Acid (PGLA)) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
出版日: 2017年02月09日 ページ情報: 英文 114 Pages
概要

当レポートでは、マトリックス誘導性自家軟骨形成市場を調査しており、市場構造や主な促進・抑制要因および市場の機会を検証し、材料、地域別の詳細な市場動向と市場予測、競合環境や主要企業のプロファイルなどをまとめています。

第1章 序章

  • 調査範囲と市場区分
  • 調査の着眼点

第2章 調査手法と仮説

  • 仮説と頭字語
  • 調査手法

第3章 エグゼクティブサマリー

  • マトリックス誘導性自家軟骨形成の世界市場:概要
  • マトリックス誘導性自家軟骨形成世界市場:市場機会マップ

第4章 市場概要

  • マトリックス誘導性自家軟骨形成の世界市場:主要産業の発展

第5章 市場力学

  • 市場の促進要因
  • 市場の抑制要因
  • 市場機会の分析
  • マトリックス誘導性自家軟骨形成の世界市場:収益予測
  • ファイブフォース分析
  • バリューチェーン分析
  • マトリックス誘導性自家軟骨形成市場の見通し

第6章 マトリックス誘導性自家軟骨形成市場の分析:材料別

  • 主な調査結果
  • 序論
  • マトリックス誘導性自家軟骨形成の市場シェア分析:製品タイプ別
  • マトリックス誘導性自家軟骨形成の市場予測:製品タイプ別
    • ヒアルロン酸
    • コラーゲン
    • ポリエチレングリコール(PEG)
    • 乳酸-グリコール酸共重合体(PGLA)
    • その他
  • 市場魅力度

第7章 マトリックス誘導性自家軟骨形成市場:地域別

  • 規制シナリオ
  • 市場シェア分析:地域別
  • 市場シェア予測:地域別
  • 市場魅力度

第8章 北米におけるマトリックス誘導性自家軟骨形成市場

  • 主な調査結果
  • 市場概要
  • 市場価値・市場シェアの分析:材料別
    • 市場予測:材料別
  • 市場予測:国別
  • 市場魅力度の分析
  • 北米市場の動向

第9章 欧州におけるマトリックス誘導性自家軟骨形成市場

  • 主な調査結果
  • 市場概要
  • 市場価値・市場シェアの分析:材料別
    • 市場予測:材料別
  • 市場予測:国別
  • 市場魅力度の分析
  • 欧州市場の動向

第10章 アジア太平洋におけるマトリックス誘導性自家軟骨形成市場

  • 主な調査結果
  • 市場概要
  • 市場価値・市場シェアの分析:材料別
    • 市場予測:材料別
  • 市場予測:国別
  • 市場魅力度の分析
  • アジア太平洋市場の動向

第11章 ラテンアメリカにおけるマトリックス誘導性自家軟骨形成市場

  • 主な調査結果
  • 市場概要
  • 市場価値・市場シェアの分析:材料別
    • 市場予測:材料別
  • 市場予測:国別
  • 市場魅力度の分析
  • ラテンアメリカ市場の動向

第12章 中東・アフリカにおけるマトリックス誘導性自家軟骨形成市場

  • 主な調査結果
  • 市場概要
  • 市場価値・市場シェアの分析:材料別
    • 市場予測:材料別
  • 市場予測:国別
  • 市場魅力度の分析
  • 中東・アフリカ市場の動向

第13章 競合環境

  • 競合マトリクス
  • 企業プロファイル
目次

Global Autologous Matrix-Induced Chondrogenesis Market: Scope and Methodology

This report on the global autologous matrix-induced chondrogenesis market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in this global market.

Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as increasing demand for minimal invasive procedures and increasing prevalence of bone and joint disorder in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Autologous Matrix-Induced Chondrogenesis Market: Segmentation

Based on the material the market has segmented into hyaluronic acid, collagen, polyethylene glycol (PEG), Poly lactic-co-glycolic acid (PGLA) and others segment. Geographically, the global market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Japan, India, Saudi Arabia, UAE, Brazil, and Mexico.

Autologous Matrix-Induced Chondrogenesis Market: Geographical and Competitive Dynamics

The report also profiles major players in this market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Anika Therapeutics, Inc., Arthro-Kinetics, B. Braun Melsungen AG, BioTissue AG, CartiHeal, Geistlich Pharma AG, JRI Orthopaedics Ltd., Matricel GmbH, Smith & Nephew plc and Zimmer Biomet Holdings.

The global autologous matrix-induced chondrogenesis market has been segmented as follows:

Global Autologous Matrix-Induced Chondrogenesis Market, by Material

  • Hyaluronic Acid
  • Collagen
  • Polyethylene Glycol (PEG)
  • Poly lactic-co-glycolic acid (PGLA
  • Others

Global Autologous Matrix-Induced Chondrogenesis Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • vLatin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

Section 1: Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

Section 2: Assumptions and Research Methodology

  • 2.1. Assumptions and Acronyms Used
  • 2.2. Research Methodology

Section 3: Executive Summary

  • 3.1. Global AMIC Market: Market Snapshot
  • 3.2. Global AMIC Market : Opportunity Map

Section 4: Market Overview

  • 4.1. Global AMIC Market : Key Industry Developments

Section 5: Market Dynamics

  • 5.1. Drivers and Restraints Snapshot Analysis
    • 5.1.2. Drivers
      • 5.1.2.1. Increasing Demand for Minimally Invasive Procedures
      • 5.1.2.2. Economically Efficient
      • 5.1.2.3. Rising Prevalence of Bone and Joint Disorders
      • 5.1.2.4. Aging Population
      • 5.1.2.5. Surge in Sports Injuries
      • 5.1.2.6. Reduces Life Risk and Faster Recovery
    • 5.1.3. Restraints
      • 5.1.3.1. Lack of Efficient Reimbursement System
      • 5.1.3.2. Lack of Extensive Clinical Data
    • 5.1.4. Opportunity Analysis
      • 5.1.4.1. Emerging Economies to Offer Sustained Growth Opportunities
      • 5.1.4.2. Extending Distribution Network by Partnership/Acquisitions
  • 5.2. Global AMIC Market Revenue Projection
  • 5.3. Porter's Five Forces Analysis
  • 5.4. Value Chain Analysis
  • 5.5. AMIC Market Outlook

Section 6: AMIC Market Analysis By Material

  • 6.1. Key Findings
  • 6.2. Introduction
  • 6.3. Global AMIC Market Value Share Analysis, By Product Type
  • 6.4. Global AMIC Market Forecast By Product Type
    • 6.4.1. Hyaluronic Acid
    • 6.4.2. Collagen
    • 6.4.3. Polyethylene glycol (PEG)
    • 6.4.4. Poly lactic-co-glycolic acid (PGLA)
    • 6.4.5. Others
  • 6.5. Global AMIC Market Attractiveness Analysis By Material

Section 7: Global AMIC Market Analysis By Region

  • 7.1. Global Regulatory Scenario
  • 7.2. Global AMIC Market Value Share Analysis, By Region
  • 7.3. Global AMIC Market Forecast, By Region
  • 7.4. Global AMIC Market Attractiveness Analysis, By Region Type

Section 8: North America AMIC Market Analysis

  • 8.1. Key Findings
  • 8.2. North America AMIC Market Overview
  • 8.3. North America Market Value Share Analysis, By Material
    • 8.3.1. North America Market Forecast By Material
  • 8.4. North America Market Forecast By Country
  • 8.5. North America Market Attractiveness Analysis
  • 8.6. North America Market Trends

Section 9: Europe AMIC Market Analysis

  • 9.1. Key Findings
  • 9.2. Europe ABC Market Overview
  • 9.3. Europe Market Value Share Analysis, By Material
    • 9.3.1. Europe Market Forecast By Material
  • 9.4. Europe Market Forecast By Country
  • 9.5. Europe Market Attractiveness Analysis
  • 9.6. Europe Market Trends

Section 10: Asia Pacific AMIC Market Analysis

  • 10.1. Key Findings
  • 10.2. Asia Pacific AMIC Market Overview
  • 10.3. Asia Pacific Market Value Share Analysis, By Material
    • 10.3.1. Asia Pacific Market Forecast By Material
  • 10.4. Asia Pacific Market Forecast By Country
  • 10.5. Asia Pacific Market Attractiveness Analysis
  • 10.6. Asia Pacific Market Trends

Section 11: Latin America AMIC Market Analysis

  • 11.1. Key Findings
  • 11.2. Latin America AMIC Market Overview
  • 11.3. Latin America Market Value Share Analysis, By Material
    • 11.3.1. Latin America Market Forecast By Material
  • 11.4. Latin America Market Forecast By Country
  • 11.5. Latin America Market Attractiveness Analysis
  • 11.6. Latin America Market Trends

Section 12: Middle East and Africa AMIC Market Analysis

  • 12.1. Key Findings
  • 12.2. Middle East and Africa AMIC Market Overview
  • 12.3. Middle East and Africa Market Value Share Analysis, By Material
    • 12.3.1. Middle East and Africa Market Forecast By Material
  • 12.4. Middle East and Africa Market Forecast By Country
  • 12.5. Middle East and Africa Market Attractiveness Analysis

Section 13: Competition Landscape

  • 13.1. Competition Matrix
  • 13.2. Company Profiles
    • 13.2.1. Anika Therapeutics, Inc.
      • 13.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.1.2. Financial Overview
      • 13.2.1.3. Product Portfolio
      • 13.2.1.4. SWOT Analysis
      • 13.2.1.5. Strategic Overview
    • 13.2.2. Arthro-Kinetics
      • 13.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.2.2. Financial Overview
      • 13.2.2.3. Product Portfolio
      • 13.2.2.4. SWOT Analysis
      • 13.2.2.5. Strategic Overview
      • 13.2.3. B. Braun Melsungen AG
      • 13.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.3.2. Financial Overview
      • 13.2.3.3. Product Portfolio
      • 13.2.3.4. SWOT Analysis
      • 13.2.3.5. Strategic Overview
    • 13.2.4. BioTissue AG
      • 13.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.4.2. Financial Overview
      • 13.2.4.3. Product Portfolio
      • 13.2.4.4. SWOT Analysis
      • 13.2.4.5. Strategic Overview
    • 13.2.5. CartiHeal
      • 13.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.5.2. Financial Overview
      • 13.2.5.3. Product Portfolio
      • 13.2.5.4. SWOT Analysis
      • 13.2.5.5. Strategic Overview
    • 13.2.6. Geistlich Pharma AG
      • 13.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.6.2. Financial Overview
      • 13.2.6.3. Product Portfolio
      • 13.2.6.4. SWOT Analysis
      • 13.2.6.5. Strategic Overview
    • 13.2.7. JRI Orthopaedics Ltd.
      • 13.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.7.2. Financial Overview
      • 13.2.7.3. Product Portfolio
      • 13.2.7.4. SWOT Analysis
      • 13.2.7.5. Strategic Overview
    • 13.2.8. Matricel GmbH
      • 13.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.8.2. Financial Overview
      • 13.2.8.3. Product Portfolio
      • 13.2.8.4. SWOT Analysis
      • 13.2.8.5. Strategic Overview
    • 13.2.9. Smith & Nephew plc
      • 13.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.9.2. Financial Overview
      • 13.2.9.3. Product Portfolio
      • 13.2.9.4. SWOT Analysis
      • 13.2.9.5. Strategic Overview
    • 13.2.10. Zimmer Biomet Holdings
      • 13.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.10.2. Financial Overview
      • 13.2.10.3. Product Portfolio
      • 13.2.10.4. SWOT Analysis
      • 13.2.10.5. Strategic Overview

List of Figures

  • Figure 01: Global Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 02: Global AMIC Market Value Share Analysis, by Material, 2016 and 2024
  • Figure 03: Global Hyaluronic Acid Market Revenue (US$ Mn), 2014-2024
  • Figure 04: Global Collagen Market Revenue (US$ Mn), 2014-2024
  • Figure 05: Global PEG Market Revenue (US$ Mn), 2014-2024
  • Figure 06: Global PGLA Market Revenue (US$ Mn), 2014-2024
  • Figure 07: Global Others Market Revenue (US$ Mn), 2014-2024
  • Figure 08: AMIC Market Attractiveness Analysis, by Material
  • Figure 09: Global AMIC Market Value Share Analysis, by Region, 2016 and 2024
  • Figure 10: AMIC Market Attractiveness Analysis, by Region
  • Figure 11: North America Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 12: North America Autologous Matrix-Induced Chondrogenesis Market Size Y-o-Y Growth Projections, 2015-2024
  • Figure 13: North America Market Attractiveness Analysis, by Country
  • Figure 14: North America AMIC Market Value Share Analysis, by Material, 2015 and 2024
  • Figure 15: North America AMIC Market Value Share Analysis, by Country, 2016 and 2024
  • Figure 16: North America Market Attractiveness Analysis, by Material
  • Figure 17: Europe Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 18: Europe Autologous Matrix-Induced Chondrogenesis Market Size Y-o-Y Growth Projections, 2015-2024
  • Figure 19: Europe Market Attractiveness Analysis, by Country
  • Figure 20: Europe AMIC Market Value Share Analysis, by Material, 2015 and 2024
  • Figure 21: Europe AMIC Market Value Share Analysis, by Country, 2015 and 2024
  • Figure 22: Europe AMIC Market Attractiveness Analysis, by Material
  • Figure 23: Asia Pacific AMIC Market Size (US$ Mn) and Forecast, 2014-2024
  • Figure 24: Asia Pacific AMIC Market Size Y-o-Y Growth Projections, 2015-2024
  • Figure 25: Asia Pacific Market Attractiveness Analysis, by Country
  • Figure 26: Asia Pacific AMIC Market Value Share Analysis, by Material, 2015 and 2024
  • Figure 27: Asia Pacific AMIC Market Value Share Analysis, by Country, 2015 and 2024
  • Figure 28: Asia Pacific AMIC Market Attractiveness Analysis, by Material
  • Figure 29: Latin America AMIC Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 30: Latin America AMIC Market Size Y-o-Y Growth Projection, 2014-2024
  • Figure 31: Latin America Market Attractiveness Analysis, by Country/Region
  • Figure 32: Latin America AMIC Market Value Share Analysis, by Material, 2015 and 2024
  • Figure 33: Latin America AMIC Market Value Share Analysis, by Country, 2015 and 2024
  • Figure 34: Latin America AMIC Market Attractiveness Analysis, by Material
  • Figure 35: Middle East & Africa AMIC Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 36: Middle East & Africa AMIC Market Size Y-o-Y Growth Projections, 2015-2024
  • Figure 37: Middle East & Africa Market Attractiveness Analysis, by Country
  • Figure 38: Middle East & Africa AMIC Market Value Share Analysis, by Material, 2015 and 2024
  • Figure 39: Middle East & Africa AMIC Market Value Share Analysis, by Country, 2016 and 2024
  • Figure 40: Middle East & Africa Market Attractiveness Analysis, by Material
  • Figure 41: Global Autologous Matrix-Induced Chondrogenesis Market Share Analysis By Company, (2015)

List of Tables

  • Table 01: Global Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, by Material, 2014-2024
  • Table 02: Global Market Size (US$ Mn) Forecast, by Region, 2014-2024
  • Table 03: North America Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, by Material, 2014-2024
  • Table 04: North America Market Size (US$ Mn) Forecast, by Country, 2014-2024
  • Table 05: Europe Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, by Material, 2014-2024
  • Table 06: Europe Market Size (US$ Mn) Forecast, by Country, 2014-2024
  • Table 07: Asia Pacific Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, by Material, 2014-2024
  • Table 08: Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2014-2024
  • Table 09: Latin America Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, by Material, 2014-2024
  • Table 10: Latin America Market Size (US$ Mn) Forecast, by Country, 2014-2024
  • Table 11: Middle East & Africa Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, by Material, 2014-2024
  • Table 12: Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2014-2024
Back to Top